Knowledge gained through genetic sequencing of tumors has led cancer centers to change treatment methods and sparked competition among drugmakers to develop targeted therapies. "What we're seeing is the beginning of a revolution in therapeutics," said Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research.
Promise of precision medicine bears fruit
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan